• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Covis’s Ferabright Receives Approval in US

    FDA

    Sandoz`s Generic Ferumoxytol Receives Approval in US

    FDA

    Analyzing Data for Earliest Market Entry for Subsequent ANDA Filers

    TWOFOUR INSIGHT

    FDA Drug Safety Communication: FDA strengthens warnings and changes prescribing instructions to decrease the risk of serious allergic reactions with anemia drug Feraheme (ferumoxytol)

    FDA

    AMAG Pharmaceuticals and Takeda Announce Mutual Termination of Agreement to License, Develop and Commercialize Ferumoxytol in Ex-U.S. Territories, Including Europe

    AMAG PHARMACEUTICALS

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.